Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Gold Bull Outlines Australian Approach to Advance Sandman

As tight capital markets force Canadian explorers to get creative with fundraising, Gold Bull Resources Corporation (TSXV:GBRC, OTC:GBRCF) has unveiled plans to look inward for sustained explorati...
Research | October 7, 2022 |

Could There Finally Be an Effective Treatment for Alzheimer's Disease?

ProMIS' preclinical treatment could possibly outshine Biogen's candidate. Finding an effective treatment for Alzheimer's disease has been elusive as many seemingly promising avenues of research did not prove out in clinical trials. Biogen Inc. (BIIB:NASDAQ) appeared...
Streetwise Reports | November 7, 2019 |

Stock Pick Update: March 18 – March 24, 2020

The corona virus and economic slowdown fears are still dominating headlines. We released our last week’s Stock Pick Update just before another wave of the broad stock market’s sell-off. Then we have seen very volatile market conditions. Was ...
Paul Rejczak | March 18, 2020 |

Stock Pick Update: January 2 – January 7, 2020

Let’s check which stock could magnify S&P’s gains in case it rallies, and which stocks would be likely to decline the most if S&P plunges. Here are our stock picks for the Thursday, January 2 – Tuesday, January 7 period. The Stock Pick Updat...
Paul Rejczak | January 3, 2020 |

Stock Pick Update: January 8 – January 14, 2020

Let’s check which stock could magnify S&P’s gains in case it rallies, and which stocks would be likely to decline the most if S&P plunges. Here are our stock picks for the Wednesday, January 8 – Tuesday, January 14 period. The Stock Pick Upd...
Paul Rejczak | January 9, 2020 |

Stock Pick Update: January 15 – January 21, 2020

Let’s check which stock could magnify S&P’s gains in case it rallies, and which stocks would be likely to decline the most if S&P plunges. Here are our stock picks for the Wednesday, January 15 – Tuesday, January 21 period. The Stock Pick Up...
Paul Rejczak | January 16, 2020 |

Stock Pick Update: February 5 – February 11, 2020

Let’s check which stock could magnify S&P’s gains in case it rallies, and which stocks would be likely to decline the most if S&P plunges. Here are our stock picks for the Wednesday, February 5 – Tuesday, February 11 period. The Stock Pick U...
Paul Rejczak | February 7, 2020 |

Stock Pick Update: January 22 – January 28, 2020

Let’s check which stock could magnify S&P’s gains in case it rallies, and which stocks would be likely to decline the most if S&P plunges. Here are our stock picks for the Wednesday, January 22 – Tuesday, January 28 period. The Stock Pick Up...
Paul Rejczak | January 22, 2020 |

Stock Pick Update: January 29 – February 4, 2020

Let’s check which stock could magnify S&P’s gains in case it rallies, and which stocks would be likely to decline the most if S&P plunges. Here are our stock picks for the Wednesday, January 29 – Tuesday, February 4 period. The Stock Pick Up...
Paul Rejczak | January 29, 2020 |

BioNTech, Bayer, Valeo Pharma: Share price jump ahead of quarterly results

Investors' expectations of developments can drive the share price. When it comes to solving a problem or creating needs, the interest of the capital market is particularly high. Things get exciting for investors when the business model offers the possibilities of scalability. ...
Mario Hose | September 29, 2020 |
1 2 3 4 5 6 7 8 9 10 ...